Researchers have created an AI tool to accelerate the development of new disease treatments and demonstrated its potential by identifying an existing drug with the potential to prevent deadly heart ...

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new ...

sold as Lexapro, may prevent harmful changes in the heart that lead to heart failure, a condition that causes almost half of all cardiovascular deaths in the United States. “AI needs to move ...

sold as Lexapro, may prevent harmful changes in the heart that lead to heart failure, a condition that causes almost half of all cardiovascular deaths in the United States. AI needs to move from ...

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The ...

The study also revealed key differences among various SSRIs: escitalopram (brand name Lexapro ... than 737,000 people who have dementia, nearly half of them received these medications.

He has been tapering off lithium for nine months under the care of a nurse-practitioner, and settled, for the moment, at 450 milligrams, half his original ... to taper off Lexapro himself.

Recent data from the United States are alarming, showing that nearly half of women stop taking ... such as sertraline, escitalopram, and citalopram, are associated with a noticeably increased ...